Incidence and Morbidity of Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer
Authors:
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapyRadiotherapy and Oncology, 2015
- A Practical Approach to the Management of Radiation-Induced Hemorrhagic CystitisDrugs, 2015
- Hemorrhagic Radiation CystitisAmerican Journal of Clinical Oncology, 2015
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trialThe Lancet Oncology, 2012
- Laparoscopic Cystoprostatectomy for Radiation-Induced Hemorrhagic CystitisJournal of Endourology, 2009
- Efficacy and Survival Associated With Cystoscopy and Clot Evacuation for Radiation or Cyclophosphamide Induced Hemorrhagic CystitisJournal of Urology, 2009
- Hypofractionated Intensity-Modulated Radiotherapy for Carcinoma of the Prostate: Analysis of ToxicityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Screening for Prostate Cancer in U.S. MenAmerican Journal of Preventive Medicine, 2008
- Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhageUrology, 1992
- Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991